National Framework Agreement for Nitric Oxide Therapy

NHS LPP has launched the National Framework Agreement for Nitric Oxide Therapy to help trusts safely and efficiently procure all products needed for the supply of nitric oxide. Nitric oxide is a medical gas commonly used in intensive care units to treat pulmonary hypertension. This framework provides a flexible procurement solution for public sector organisations when procuring nitric oxide


Benefits of the contract

Specific benefits of the framework include:

  • Direct award option
  • Standardised forms of contract
  • Simplify the procurement process for public sector organisations to procure nitric oxide
  • Discounted prices under certain conditions
  • Streamlined contract management process for the overarching framework

Contract description

The framework has been split into 2 lots, however contract was awarded for Lot 1 only:

Lot 1 a complete system to deliver Nitric Oxide Therapy that includes nitric oxide in cylinders, delivery and monitoring devices and all ancillary equipment, maintenance and consumables.

Lot 2 was for the monitoring and delivery devices for use in aircraft and ambulances, however no bid was submitted for this particular lot.

 


Suppliers

  • BOC Ltd
  • BTG Gases
Contract Overview
Start 06-05-20
End 05-05-22
Contract Type Framework (Call Off)
Accessible to All NHS
Authority Guy's & St Thomas' NHS Foundation Trust
OJEU Award Ref 2020/S 029-068821
Initial Period (Years) 2.00
Extensions remaining 2.00
LPP Contact Jackie Eastwood
07500 573068
jacqueline.eastwood@lpp.nhs.uk
LPP Ref LPP/2020/001